AUSTRALIAN SAFETY AGENCY ORDERS ELEKTA SYNERGY® AS GOLD STANDARD FOR CALIBRATION AND DOSIMETRY

AUSTRALIAN SAFETY AGENCY ORDERS ELEKTA SYNERGY® AS GOLD STANDARD FOR CALIBRATION
AND DOSIMETRY

Press Release 
Stockholm, Sweden, May 19, 2008

Elekta, world-leading provider of radiation therapy and radiosurgery solutions,
is pleased to announce that the Australian Radiation Protection and Nuclear
Safety Agency (ARPANSA) has joined other world-class physics standards centers
with its order of an Elekta linear accelerator. ARPANSA will accept delivery of
an Elekta Synergy® system this summer, and will utilize the Elekta system's high
level of stability for its national physics measurements.

“It's very gratifying to add another prestigious physics standards laboratory to
our group of Elekta users, who are so confident in the stability of Elekta
Synergy that they chose our product to benchmark even non-clinical equipment and
the equipment of other manufacturers,” says Kevin Brown, Ph.D. and Advanced
Research Director at Elekta. “To have Elekta equipment serve not only as
innovative solutions for treating serious disease, but also as global gold
standards for accuracy in physics, is a testimony to the reliability of these
systems.”

Dr. Brown adds that Elekta Synergy and other systems in Elekta's portfolio of
digital linear accelerators are traveling wave accelerators that use a magnetron
as the microwave source. Other commercially available linear accelerators use a
standing wave/klystron configuration. 

ARPANSA joins several other centers that have acquired Elekta equipment for
testing: The National Physical Laboratory (NPL) in the U.K., The National
Research Council (NRC) in Ottawa, Canada and The Physikalisch-Technische
Bundesanstalt (PTB) in Germany.  
“In addition to stability, versatility has also been a key factor in these
purchases,” Dr. Brown says. “These centers need to perform calibrations at a
wide range of energies, which our systems have always accommodated.” 

Elekta Synergy is an advanced digital linear accelerator that integrates a suite
of imaging tools to enable high quality, 3D imaging from the treatment control
console at the time of treatment. This capability provides clinicians with a
solution to the two most persistent and significant problems in radiation
therapy: internal organ motion and errors in patient set-up. The result is
unmatched clinical confidence to more aggressively treat tumors, while
minimizing damage to surrounding healthy tissue. Elekta Synergy is in routine
clinical use at hundreds of centers worldwide.

******



For further information, please contact:

Peter Ejemyr, Group VP Corporate Communications.
Tel: +46 733 611 000 (mobile), e-mail: peter.ejemyr@elekta.com  

About Elekta

Elekta is an international medical technology group, providing oncologists,
radiation therapists, neurosurgeons and many other medical specialists with
state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and
information systems as well as services for improved cancer care and management
of brain disorders. 

Elekta's systems and solutions are used in over 5,000 hospitals around the
world. Clinical and information management solutions include, among others,
Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta
Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy
and radiosurgery as well as the MOSAIQ™ suite of software for image-enabled EMR
and efficient management of clinical and patient data.

With around 2,500 employees globally, the corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Nordic Exchange under the
ticker EKTAb. More information about Elekta can be found at www.elekta.com.